Jubilant Life's Nanjangud facility may face regulatory action by USFDA

Jubilant Life Sciences said USFDA's announcement will not have any impact on the existing revenues from operations of this facility.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2U6Vkwg
via IFTTT